Evercore ISI cuts Prudential Financial stock price target on Japan sales suspension

Evercore ISI cut Prudential Financial’s price target to $95 from $110 while keeping an In Line rating after the company extended its Prudential of Japan sales suspension by 180 days. Prudential now expects an additional $200 million pre-tax earnings drag in 2026 and $425 million in 2027, with in-force earnings in Japan seen declining 10% and 15% versus 2025 baseline. Management said the issue should not materially affect capital or cash flow, but analysts also highlighted heightened cost and regulatory risk.

Analysis

PRU’s issue is no longer an isolated operating hiccup; it is a multi-quarter earnings reset in one of its highest-margin adjacent businesses, and the market is still likely underestimating the duration of the drag because the compensation fix creates an expense bridge before any revenue bridge. The key second-order effect is that sustaining a distribution force without active sales tends to preserve fixed costs while degrading morale and retention, which can make the post-suspension rebound slower than management models. That means the 2027 estimate cut may still prove too conservative if the ramp back is delayed or if productivity per adviser resets lower.

The bigger debate is capital versus earnings quality. If this truly does not impair capital, then the stock should eventually stabilize on dividend support; but for insurers, repeated guidance misses in a low-growth segment typically compress the multiple first and force investors to re-rate the franchise on normalized ROE rather than stated EPS. The market may be treating the Japan issue as temporary, yet the regulatory and governance overhang can bleed into other international initiatives, raising the cost of growth elsewhere even if the direct dollar impact stays contained.

From a timing perspective, the near-term setup is still negative because estimate revisions are not finished and multiple compression often persists for several weeks after a company quantifies a multi-year drag. The contrarian point is that the selloff may be close to exhausting itself if the dividend is defended and no capital action is required; at ~10x earnings the stock is not expensive, but it is only cheap if the post-2027 earnings base is durable. The cleaner catalyst for a turn would be evidence that the revamped compensation model improves retention without further extending the suspension window.

Key Decisions for Investors

• Short PRU tactically for 4-8 weeks on any strength into the mid/high-90s; risk/reward favors a move toward the low-90s if analysts continue cutting 2026-2027 EPS and the market discounts a slower Japan restart.
• For income accounts, hold but do not add to PRU until management gives proof points on Japan adviser retention and post-suspension productivity; the dividend cushions downside, but the multiple can still compress another 1-1.5 turns on governance overhang.
• Pair trade: long a higher-quality U.S. life/retirement peer and short PRU over the next quarter to isolate Japan execution risk from sector beta; look for a relative underperformance window while revisions are still flowing.
• Buy downside protection via 1-3 month put spreads on PRU rather than outright puts; implied vol should remain supported by analyst downgrades, but the thesis is a controlled grind lower, not a crash.
• Reassess only after the next update on Japan sales resumption and adviser economics; if management can show a sub-12 month recovery path, the stock can rerate back toward book-value support, but without that, value screens are likely a trap.